News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,672 Results
Type
Article (43764)
Company Profile (473)
Press Release (695423)
Multimedia
Podcasts (127)
Webinars (20)
Section
Business (209347)
Career Advice (2042)
Deals (36158)
Drug Delivery (123)
Drug Development (83988)
Employer Resources (174)
FDA (16706)
Job Trends (15193)
News (354233)
Policy (33290)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2663)
Accelerated approval (38)
Adcomms (28)
Allergies (153)
Alliances (51111)
ALS (184)
Alzheimer's disease (1744)
Antibody-drug conjugate (ADC) (344)
Approvals (16956)
Artificial intelligence (569)
Autoimmune disease (170)
Automation (44)
Bankruptcy (373)
Best Places to Work (11840)
BIOSECURE Act (20)
Biosimilars (198)
Biotechnology (331)
Bladder cancer (168)
Brain cancer (62)
Breast cancer (665)
Cancer (5082)
Cardiovascular disease (431)
Career advice (1728)
Career pathing (39)
CAR-T (297)
CDC (50)
Celiac Disease (2)
Cell therapy (797)
Cervical cancer (37)
Clinical research (71608)
Collaboration (1855)
Company closure (4)
Compensation (1205)
Complete response letters (68)
COVID-19 (2777)
CRISPR (103)
C-suite (925)
Cystic fibrosis (152)
Data (6509)
Decentralized trials (2)
Denatured (41)
Depression (147)
Diabetes (515)
Diagnostics (6799)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (279)
Drug pricing (199)
Drug shortages (29)
Duchenne muscular dystrophy (254)
Earnings (91717)
Editorial (62)
Employer branding (21)
Employer resources (153)
Events (121415)
Executive appointments (1026)
FDA (19947)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1574)
Gene editing (222)
Generative AI (46)
Gene therapy (666)
GLP-1 (1026)
Government (4772)
Grass and pollen (6)
Guidances (386)
Healthcare (19223)
HIV (70)
Huntington's disease (49)
IgA nephropathy (88)
Immunology and inflammation (281)
Immuno-oncology (70)
Indications (126)
Infectious disease (3067)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (125)
Intellectual property (263)
Interviews (316)
IPO (16935)
IRA (53)
Job creations (3714)
Job search strategy (1440)
JPM (67)
Kidney cancer (18)
Labor market (87)
Layoffs (582)
Leadership (35)
Legal (8029)
Liver cancer (94)
Longevity (17)
Lung cancer (686)
Lymphoma (389)
Machine learning (44)
Management (59)
Manufacturing (843)
MASH (173)
Medical device (13946)
Medtech (14006)
Mergers & acquisitions (20318)
Metabolic disorders (1349)
mRNA (184)
Multiple sclerosis (171)
NASH (19)
Neurodegenerative disease (354)
Neuropsychiatric disorders (98)
Neuroscience (3082)
Neurotech (1)
NextGen: Class of 2026 (6771)
Non-profit (4586)
Now hiring (69)
Obesity (647)
Opinion (291)
Ovarian cancer (170)
Pain (212)
Pancreatic cancer (243)
Parkinson's disease (307)
Partnered (34)
Patents (521)
Patient recruitment (533)
Peanut (60)
People (60423)
Pharmaceutical (85)
Pharmacy benefit managers (31)
Phase 1 (22524)
Phase 2 (31570)
Phase 3 (23336)
Pipeline (5811)
Policy (309)
Postmarket research (2602)
Preclinical (9626)
Press Release (67)
Prostate cancer (259)
Psychedelics (56)
Radiopharmaceuticals (309)
Rare diseases (939)
Real estate (6066)
Recruiting (71)
Regulatory (25149)
Reports (53)
Research institute (2493)
Resumes & cover letters (355)
Rett syndrome (28)
RNA editing (21)
RSV (81)
Schizophrenia (158)
Series A (265)
Series B (204)
Service/supplier (11)
Sickle cell disease (109)
Special edition (27)
Spinal muscular atrophy (162)
Sponsored (43)
Startups (3808)
State (2)
Stomach cancer (19)
Supply chain (108)
Tariffs (85)
The Weekly (84)
Vaccines (1048)
Venture capital (96)
Weight loss (420)
Women's health (100)
Worklife (20)
Date
Today (240)
Last 7 days (925)
Last 30 days (2908)
Last 365 days (30871)
2026 (4896)
2025 (31063)
2024 (36297)
2023 (41014)
2022 (52277)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33023)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29221)
2011 (29863)
2010 (27992)
Location
Africa (754)
Alabama (92)
Alaska (7)
Arizona (324)
Arkansas (15)
Asia (40750)
Australia (6773)
California (11819)
Canada (3373)
China (1161)
Colorado (496)
Connecticut (510)
Delaware (344)
Europe (89440)
Florida (1755)
Georgia (372)
Hawaii (3)
Idaho (61)
Illinois (912)
India (71)
Indiana (540)
Iowa (24)
Japan (451)
Kansas (131)
Kentucky (43)
Louisiana (28)
Maine (72)
Maryland (1436)
Massachusetts (8568)
Michigan (337)
Minnesota (646)
Mississippi (6)
Missouri (131)
Montana (34)
Nebraska (29)
Nevada (125)
New Hampshire (85)
New Jersey (3142)
New Mexico (31)
New York (3086)
North Carolina (1567)
North Dakota (9)
Northern California (5786)
Ohio (351)
Oklahoma (21)
Oregon (45)
Pennsylvania (2367)
Puerto Rico (24)
Rhode Island (50)
South America (1122)
South Carolina (68)
South Dakota (1)
Southern California (4587)
Tennessee (180)
Texas (1812)
United States (41966)
Utah (355)
Vermont (1)
Virginia (278)
Washington D.C. (82)
Washington State (972)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
739,672 Results for "serina therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
February 25, 2026
·
6 min read
Press Releases
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
February 19, 2026
·
5 min read
Press Releases
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease
January 29, 2026
·
5 min read
Press Releases
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
December 12, 2025
·
6 min read
Press Releases
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
December 11, 2025
·
6 min read
Press Releases
Serina Therapeutics Provides Regulatory Update on SER-252 Program
November 4, 2025
·
6 min read
Press Releases
Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
November 13, 2025
·
12 min read
Press Releases
Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference
July 28, 2025
·
3 min read
Press Releases
Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 8, 2025
·
3 min read
Press Releases
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
October 6, 2025
·
3 min read
1 of 73,968
Next
